Pricing Log in Create free account

Editas Medicine, Inc. (EDIT) vs Entera Bio Ltd. (ENTX)

Editas Medicine, Inc. and Entera Bio Ltd. are both Biotechnology companies. Editas Medicine, Inc. and Entera Bio Ltd. are of similar size ($462.4M and $445.4M). Entera Bio Ltd. grew revenue faster over the last twelve months: 66.4% against 20.8%. Entera Bio Ltd. has the higher net margin (0.00% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Editas Medicine, Inc. leads on 9 and Entera Bio Ltd. on 7.

Valuation

Metric EDIT ENTX Biotechnology median
P/E n/m n/m 8.56
P/S 6.98 599.53 10.17
P/B 3.12 18.40 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 3.17 534.34 9.64
Earnings yield (27.27%) (13.21%) (29.41%)
Free cash flow yield (36.66%) (8.22%) (23.50%)

Profitability

Metric EDIT ENTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (161.39%) 0.00% 0.00%
Net margin (157.32%) 0.00% 0.00%
Free cash flow margin (255.88%) 0.00% 0.00%
Return on equity (118.82%) (138.92%) (56.66%)
Return on assets (33.02%) (87.02%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EDIT ENTX Biotechnology median
Revenue growth (TTM) 20.83% 66.42% 5.64%
EPS growth (last fiscal year) 37.50% 0.00% 30.08%
Revenue growth, 5-year CAGR (14.89%) (29.19%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDIT ENTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.19 8.98 4.72
Net debt to EBITDA 0.94 1.29 0.96

Dividend

Metric EDIT ENTX Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric EDIT ENTX Biotechnology median
Market cap 445.38m 462.40m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack